摘要
目的探讨神经节苷脂对急性脑出血患者的临床疗效和安全性。方法选择急性脑出血患者60例,随机分为对照组和治疗组,每组30例。对照组给予急性期常规治疗,治疗组在此基础上加用神经节苷脂治疗,比较2组患者的NIHSS评分和ADL评分结果。结果 2组患者治疗后的NIHSS评分均较治疗前显著下降(P<0.05),ADL评分均较治疗前显著提高(P<0.05),且治疗组治疗后NIHSS评分显著低于对照组(P<0.05),ADL评分显著高于对照组(P<0.05)。结论脑出血患者急性期应用神经节苷脂治疗,能够保护患者神经功能并感受患者预后,值得临床推广。
Objective To explore the clinical efficacy and safety of ganglion glycosides ester to acute cerebral hemorrhage patients.Methods Sixty patients with acute cerebral hemorrhage were chosen and randomly divided into control group and treatment group,30 cases in each.The control group was given acute phase conventional treatment,and the treatment group was added with a ganglion glycosides ester.The two groups were compared in terms of NIHSS score and ADL scores,etc.Results The NIHSS score of the two groups after treatment decreased markedly compared with before treatment （P ＜ 0.05）.ADL scores,compared to before treatment,increased （P＜0.05）,but compared with the same period,NIHSS score of the treatment group after treatment was significantly lower than that of the control group （P ＜ 0.05）,and ADL score of the treatment group was significantly higher than the control group （P ＜ 0.05）.Conclusion The patients with cerebral hemorrhage in the acute phase application ganglion glycosides ester can protect patients nerve function,and improve the prognosis.It is worth clinical promotion.
出处
《实用临床医药杂志》
CAS
2013年第16期61-62,67,共3页
Journal of Clinical Medicine in Practice
关键词
脑出血
急性期
神经节苷脂
cerebral hemorrhage
acute phase
ganglion glycosides ester
